CAS 1224844-38-5 appears in our catalog under these names: INK 128(MLN0128), 3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine, >95% (HPLC), Sapanisertib/ 99.34% (existing batch purity), MLN0128, Sapanisertib. Offered by: GLPBio, TRC, TargetMol, Chemat, Biosynth. Available pack sizes: 5mg, 50mg, 1mg, 2mg, 10mg, 25mg, 100mg, 500mg.
Sapanisertib is a 1,3-benzoxazole substituted by amino and 4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl groups at positions 2 and 5, respectively. It is a ATP-competitive inhibitor of mTORC1 and mTORC2 that exhibits antineoplastic activity. It has a role as an antineoplastic agent, an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor, a mTOR inhibitor and an apoptosis inducer. It is an aromatic amine, a pyrazolopyrimidine, a primary amino compound and a member of 1,3-benzoxazoles.
Source: ChEBI
| Molecular formula | C15H15N7O |
|---|---|
| Molecular weight | 309.33 g/mol |
| IUPAC name | 5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine |
| InChIKey | GYLDXIAOMVERTK-UHFFFAOYSA-N |
| SMILES | CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N |
Computed by PubChem (NCBI)